| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/09/2003 | US20030008352 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008351 Nucleotide sequences coding polypeptide for use in the treatment of heart defects |
| 01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
| 01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/09/2003 | US20030008348 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008347 Diagnosis and treatment of ALP related disorders |
| 01/09/2003 | US20030008346 MMSC1 - an MMAC1 interacting protein |
| 01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
| 01/09/2003 | US20030008343 Mammalian cytokines; related reagents |
| 01/09/2003 | US20030008342 Vaccine for use in the treatment and prevention of cancer, autoimmune disease, human viral infections |
| 01/09/2003 | US20030008334 Protein for use in the diagnosis, prevention and treatment of cancer |
| 01/09/2003 | US20030008332 Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 01/09/2003 | US20030008330 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cancer and autoimmune disease |
| 01/09/2003 | US20030008329 Receptor protein for use in the treatment of stomach ulcer, diabetes, alzheimer's and brain disorders |
| 01/09/2003 | US20030008311 Histone-like protein |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/09/2003 | US20030008300 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds |
| 01/09/2003 | US20030008299 Nucleotide sequences coding polypeptides for use in the treatment of cancer |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008293 Detection of polymorphism in preferential nucleotide sequences; obtain cells, extract nucleotide sequences, incubate with probe, detect signal, monitor hybridization pattern |
| 01/09/2003 | US20030008291 Protein for use in diagnosis and treatment of cancer |
| 01/09/2003 | US20030008289 Nucleotide sequences coding receptor proteins; for use in the treatment of pain, cardiovascular, and gastrointestinal disorders |
| 01/09/2003 | US20030008284 Polynucleotides related to colon cancer |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008277 Nucleotide sequences coding polypeptide for use in the prevention of viral diseases |
| 01/09/2003 | US20030008275 Attenuated HIV strains and use thereof |
| 01/09/2003 | US20030008274 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of viral diseases |
| 01/09/2003 | US20030008273 Methods for increasing the survival of neuronal cells |
| 01/09/2003 | US20030008000 DNA vaccine using liposome-encapsulated plasmid DNA encoding for hemagglutinin protein of influenza virus |
| 01/09/2003 | US20030007981 Vaccine, diagnosis of infection |
| 01/09/2003 | US20030007980 Urease-based vaccine and treatment for helicobacter infection |
| 01/09/2003 | US20030007979 Intranasal administering |
| 01/09/2003 | US20030007978 Quantiative analysis; genetic engineering |
| 01/09/2003 | US20030007976 Anticancer agents; sensitivity to Mycobacterium |
| 01/09/2003 | US20030007968 Administering bone marrow cells with lymphyocytes removed; then busulfan |
| 01/09/2003 | US20030007967 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/09/2003 | US20030007956 Proteins that interact with betaTrCP |
| 01/09/2003 | US20030007952 Polypeptides |
| 01/09/2003 | CA2453864A1 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | CA2452390A1 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | CA2452364A1 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | CA2452196A1 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | CA2452195A1 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2451959A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 01/09/2003 | CA2451850A1 Medicinal compositions |
| 01/09/2003 | CA2451846A1 Cancer vaccine comprizing a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome |
| 01/09/2003 | CA2451795A1 Cell-based high-throughput screening methods |
| 01/09/2003 | CA2451739A1 Hcv e1e2 vaccine compositions |
| 01/09/2003 | CA2451473A1 Process of purification of amyloid fibrils |
| 01/09/2003 | CA2451317A1 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | CA2451236A1 Peptides for use as translocation factors |
| 01/09/2003 | CA2450710A1 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | CA2449238A1 Alteration of oil traits in plants |
| 01/09/2003 | CA2448059A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/09/2003 | CA2448020A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/09/2003 | CA2441208A1 Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics |
| 01/09/2003 | CA2392756A1 Dna vaccine against staphylococcus aureus |
| 01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
| 01/08/2003 | EP1273914A1 Hypotensors |
| 01/08/2003 | EP1273667A1 High throughput identification of modulators of angiogenesis |
| 01/08/2003 | EP1273666A1 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 01/08/2003 | EP1273662A2 Reversible nuclear genetic system for male sterility in transgenic plants |
| 01/08/2003 | EP1273660A2 Human sodium-hydrogen exchanger like protein 1 |
| 01/08/2003 | EP1273659A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/08/2003 | EP1273658A1 Novel protein, dna thereof and process for producing the same |
| 01/08/2003 | EP1273657A1 Novel protein, process for producing the same and use thereof |
| 01/08/2003 | EP1273656A1 Use of inhibitors of expression or activity of p8/com1 for treating tumours |
| 01/08/2003 | EP1273655A1 Process for producing recombinant protein |
| 01/08/2003 | EP1273654A1 BAD as substrate for PP2C |
| 01/08/2003 | EP1273593A1 Isolation and purification of clostridium botulinum toxins |
| 01/08/2003 | EP1273592A2 Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2003 | EP1273308A1 Peptide-flavonoid conjugates, their preparation and use in uv protection |
| 01/08/2003 | EP1273239A1 Composition comprising partly-hydrolyzed fish gelatin and use thereof. |
| 01/08/2003 | EP1272845A1 SOLUTION AND CRYSTAL STRUCTURES OF ZipA AND ZipA COMPLEX AND USES THEREOF |
| 01/08/2003 | EP1272844A2 Hormone receptor functional entities and methods of their use |
| 01/08/2003 | EP1272677A1 Suppressor of hiv replication and transcription |
| 01/08/2003 | EP1272670A2 Diagnosis of diseases associated with dna adducts |
| 01/08/2003 | EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 01/08/2003 | EP1272651A2 Control of fruit dehiscence in arabidopsis by indehiscent1 genes |
| 01/08/2003 | EP1272650A2 Maize cellulose synthases and uses thereof |
| 01/08/2003 | EP1272649A2 Method for producing authentic cytokines in plants |
| 01/08/2003 | EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272634A1 Human ion channel protein and polynucleotides encoding the same |
| 01/08/2003 | EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy |
| 01/08/2003 | EP1272632A1 Dna immunization vectors |
| 01/08/2003 | EP1272631A2 Regulation of human hm74-like g protein coupled receptor |
| 01/08/2003 | EP1272624A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 01/08/2003 | EP1272622A1 Method for modification of proteins by transglutaminase |
| 01/08/2003 | EP1272612A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 01/08/2003 | EP1272610A1 Mutant bank |
| 01/08/2003 | EP1272524A1 Agent against periodontal disease |
| 01/08/2003 | EP1272523A1 Human emr2, a g-protein coupled receptor from the egf-tm7 family |
| 01/08/2003 | EP1272522A1 Selectable marker genes |
| 01/08/2003 | EP1272521A2 Regulation of human oatp2-related protein |
| 01/08/2003 | EP1272520A2 Gpcr-proteins and nucleic acids encoding same |
| 01/08/2003 | EP1272519A2 Regulation of human neuropeptide y-like g protein-coupled receptor |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |